Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.390
0.00 (0.00%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Pulmonx Revenue
Pulmonx had revenue of $20.59M in the quarter ending March 31, 2026, a decrease of -8.66%. This brings the company's revenue in the last twelve months to $88.55M, up 1.23% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth.
Revenue (ttm)
$88.55M
Revenue Growth
+1.23%
P/S Ratio
0.66
Revenue / Employee
$299,139
Employees
296
Market Cap
58.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 90.50M | 6.71M | 8.01% |
| Dec 31, 2024 | 83.79M | 15.11M | 22.01% |
| Dec 31, 2023 | 68.68M | 15.01M | 27.98% |
| Dec 31, 2022 | 53.66M | 5.25M | 10.84% |
| Dec 31, 2021 | 48.42M | 15.68M | 47.91% |
| Dec 31, 2020 | 32.73M | 138.00K | 0.42% |
| Dec 31, 2019 | 32.60M | 12.59M | 62.94% |
| Dec 31, 2018 | 20.00M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xtant Medical Holdings | 121.91M |
| Nortech Systems | 121.79M |
| LENSAR | 57.70M |
| electroCore | 34.90M |
| QT Imaging Holdings | 22.66M |
| Sensus Healthcare | 22.53M |
| Spectral AI | 16.93M |
| Elutia | 12.46M |
LUNG News
- 4 weeks ago - Pulmonx Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Pulmonx Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Pulmonx reports Q1 EPS (33c), consensus (33c) - TheFly
- 2 months ago - Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.87M - TheFly
- 2 months ago - Pulmonx Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Pulmonx Earnings release: Q1 2026 - Filings
- 2 months ago - Pulmonx Quarterly report: Q1 2026 - Filings